Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 277
8
Diseases
13
Unique genes
0.242
Avg. similarity score
Cleft lip with or without cleft palate
Most-connected disease (6 links)
Disease
Searched: Atypical lobular breast hyperplasia
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Atypical lobular breast hyperplasia
Cleft lip with or without cleft palate
Blepharocheilodontic syndrome
Hereditary diffuse gastric and lobular breast cancer syndrome
Diffuse gastric and lobular breast cancer syndrome
Trigeminal nerve disease
Bilateral cleft lip
Non-syndromic orofacial cleft
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Cleft lip with or without cleft palate | 6 | 6 | 6 |
| Blepharocheilodontic syndrome | 5 | 5 | 2 |
| Atypical lobular breast hyperplasia | 4 | 4 | 2 |
| Hereditary diffuse gastric and lobular breast cancer syndrome | 4 | 4 | 1 |
| Diffuse gastric and lobular breast cancer syndrome | 3 | 3 | 2 |
| Trigeminal nerve disease | 2 | 2 | 6 |
| Bilateral cleft lip | 1 | 1 | 1 |
| Non-syndromic orofacial cleft | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| CDH1 | 5 / 8 | Atypical lobular breast hyperplasia, Blepharocheilodontic syndrome, Cleft lip with or without cleft palate, Diffuse gastric and lobular breast cancer syndrome and 1 more |
| CTNND1 | 3 / 8 | Blepharocheilodontic syndrome, Cleft lip with or without cleft palate, Trigeminal nerve disease |
| ARHGAP29 | 2 / 8 | Cleft lip with or without cleft palate, Non-syndromic orofacial cleft |
| PLEKHA5 | 2 / 8 | Bilateral cleft lip, Cleft lip with or without cleft palate |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Adherens junction | KEGG | 4 / 93 | 39.7× | 2.28e-6 | 8.44e-5 ✓ sig. |
| Adherens junctions interactions | Reactome | 3 / 32 | 86.6× | 4.83e-6 | 1.60e-4 ✓ sig. |
| Endometrial cancer | KEGG | 3 / 59 | 47.0× | 3.11e-5 | 7.47e-4 ✓ sig. |
| InlA-mediated entry of Listeria monocytogenes into host cells | Reactome | 2 / 9 | 205× | 3.88e-5 | 8.92e-4 ✓ sig. |
| Bacterial invasion of epithelial cells | KEGG | 3 / 78 | 35.5× | 7.19e-5 | 1.46e-3 ✓ sig. |
| Leukocyte transendothelial migration | KEGG | 3 / 116 | 23.9× | 2.34e-4 | 3.71e-3 ✓ sig. |
| VEGFR2 mediated vascular permeability | Reactome | 2 / 29 | 63.7× | 4.32e-4 | 5.96e-3 ✓ sig. |
| Gastric cancer | KEGG | 3 / 150 | 18.5× | 4.98e-4 | 6.67e-3 ✓ sig. |
| RHO GTPases activate IQGAPs | Reactome | 2 / 32 | 57.7× | 5.27e-4 | 6.95e-3 ✓ sig. |
| Synthesis of PIPs at the plasma membrane | Reactome | 2 / 51 | 36.2× | 1.34e-3 | 1.41e-2 ✓ sig. |
| Rap1 signaling pathway | KEGG | 3 / 211 | 13.1× | 1.34e-3 | 1.42e-2 ✓ sig. |
| Melanoma | KEGG | 2 / 73 | 25.3× | 2.72e-3 | 2.38e-2 ✓ sig. |
| MET activates PI3K/AKT signaling | Reactome | 1 / 6 | 154× | 6.48e-3 | 4.32e-2 ✓ sig. |
| IRS-mediated signalling | Reactome | 1 / 6 | 154× | 6.48e-3 | 4.32e-2 ✓ sig. |
| PI3K/AKT activation | Reactome | 1 / 9 | 103× | 9.70e-3 | 5.59e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| cell-cell adhesion mediated by cadherin | GO:0044331 | 4 / 42 | 137× | 1.55e-8 | 2.59e-6 ✓ sig. |
| cell-cell adhesion | GO:0098609 | 5 / 218 | 33.0× | 2.46e-7 | 2.69e-5 ✓ sig. |
| cellular response to indole-3-methanol | GO:0071681 | 2 / 5 | 575× | 4.46e-6 | 2.89e-4 ✓ sig. |
| epithelial cell-cell adhesion | GO:0090136 | 2 / 12 | 240× | 2.94e-5 | 1.23e-3 ✓ sig. |
| establishment or maintenance of cell polarity | GO:0007163 | 2 / 43 | 66.9× | 3.97e-4 | 8.13e-3 ✓ sig. |
| negative regulation of blood vessel branching | GO:1905554 | 1 / 1 | 1,437× | 6.96e-4 | 1.18e-2 ✓ sig. |
| response to butyrate | GO:1903544 | 1 / 1 | 1,437× | 6.96e-4 | 1.18e-2 ✓ sig. |
| cell adhesion | GO:0007155 | 4 / 665 | 8.6× | 8.79e-4 | 1.36e-2 ✓ sig. |
| cell migration | GO:0016477 | 3 / 303 | 14.2× | 1.07e-3 | 1.51e-2 ✓ sig. |
| negative regulation of miRNA catabolic process | GO:2000626 | 1 / 2 | 719× | 1.39e-3 | 1.75e-2 ✓ sig. |
| ureteric bud invasion | GO:0072092 | 1 / 2 | 719× | 1.39e-3 | 1.75e-2 ✓ sig. |
| response to muscle inactivity | GO:0014870 | 1 / 2 | 719× | 1.39e-3 | 1.75e-2 ✓ sig. |
| positive regulation of protein localization to cell-cell junction | GO:0150107 | 1 / 3 | 479× | 2.09e-3 | 2.17e-2 ✓ sig. |
| condensed mesenchymal cell proliferation | GO:0072137 | 1 / 3 | 479× | 2.09e-3 | 2.17e-2 ✓ sig. |
| cellular response to hydrostatic pressure | GO:0071464 | 1 / 3 | 479× | 2.09e-3 | 2.17e-2 ✓ sig. |